Maryann has over 25 years of experience in the healthcare sector spanning retail/specialty pharmacy, biotechnology and management consulting. Maryann’s focus has been to provide strategic and tactical direction to the optimize channel strategy across a number of franchises leveraging the specialty pharmacy distribution channel in support of the desired patient service model.

She has held various leadership roles at Mallinckrodt, Biogen Idec, PriceWaterhouse Coopers, EMD Serono and CVS Health. She has provided thought leadership in the management of multi-sponsored REMS programs and led an innovative limited distribution track and trace program designed to mitigate diversion and counterfeiting of high target biologics. Maryann has successfully launched several biologics products in to the specialty space and continues to provide expertise focused on continuous model improvement.

Maryann practiced pharmacy at CVS Health in Massachusetts after graduating from Mass College of Pharmacy. She is a member of the editorial board of Specialty Pharmacy Times and a member of the National Association of Specialty Pharmacy. She is a frequent speaker at key trade conferences.

Maryann is a Registered Pharmacist in Massachusetts.

Adam J. Fein, Ph.D., is the president of Pembroke Consulting, Inc., a management advisory and business research firm based in Philadelphia. He also is the CEO of Pembroke’s Drug Channels Institute, a leading management educator for and about the pharmaceutical industry.

Dr. Fein is one of the country’s foremost experts on pharmaceutical economics and the drug distribution system. Top manufacturers call on Dr. Fein’s insights and judgment to create successful commercial strategies and make better strategic decisions in our evolving healthcare environment.

Dr. Fein’s popular and influential Drug Channels website (DrugChannels.net) is the go-to source for definitive and comprehensive industry analysis, delivered with a witty edge. He has published hundreds of academic and industry articles, and is regularly quoted in such national publications as The Wall Street Journal, The New York Times, Fortune, Drug Benefit News, and many others.

Dr. Fein earned his doctoral degree from the Wharton School of Business at the University of Pennsylvania and a B.A., summa cum laude, from Brandeis University. He lives in Philadelphia with his wife and their two children.

Salvador Grausso is Vice President U.S. Patient Access for the Endo Branded Pharmaceutical Business leading a team responsible to ensure patient access to our medicines and building the market access capability.

Sal has 20 years of experience in the Pharmaceutical Industry building up market access and commercial expertise in both the domestic and international arenas. He came to Endo from Celgene where he led Market Access for the Inflammation and Immunology division. Prior he was with Merck where he Led Global Pricing and helped build the international Market Access capability.

Sal has a masters degree in Accounting from Farleigh Dickinson University and is presently pursuing his doctorate degree in Health Technology Assessment (HTA) at the University for Health Sciences, Medical Informatics and Technology (UMIT) in Hall in Tirol, Austria.

Jon Haas is the Director, Market Access and Channel Management for the Theratechnologies Market Access Team, where he is responsible for market access and channel management. Previously, Jon was with Asembia, LLC. where he was the Senior Director, Trade Relations. In his previous role, he developed HUB support services, commercialization strategies and specialty pharmacy & distribution network solutions to manufacturing partners. Jon has been in the pharmaceutical industry for over 32 years and is well versed in market and patient access solutions, specialty pharmacy/distribution and patient/provider support programs. Jon has previously developed and lead market access and payer focused initiatives for specialty pharmaceutical manufacturers, service providers and consultants with such companies as Palio (inVentiv Health), AmerisourceBergen, McKesson, Serono and Abbott Laboratories.

Rob joined Express Scripts in 2005 and is currently the V.P., Business Development Pharma and Biotech. Rob has extensive knowledge of the PBM, Specialty Pharmacy, Specialty Distribution, and Patient Access Services (REMS, PAP, Reimbursement, Nursing Services). He is a subject matter expert in the development and enhancement of the Specialty Pharmacy and Specialty Distribution channels for new and existing specialty products. Rob has responsibility for business development for pharmaceutical and biotech client’s strategies in order to successfully contract and maximize distribution channel strategies. This involves providing a single source solution for all patient access, specialty pharmacy, and specialty distribution channel needs.

Rob holds an M.B.A. from the Crummer Graduate School of Business at Rollins College and a B.A. in Biology from Indiana University.

Ms. Pigg is a forward thinking health care executive who has diverse experience with a broad array of health care organizations and products including commercial, Medicare and Medicaid lines of business. In her role as SVP/Chief Pharmacy Officer for Gateway, Cynthia combines her expertise in strategic planning with tactical practices to manage the pharmacy department’s financial performance, cost management and containment, policies and quality improvement, while maintaining high levels of member satisfaction. As the senior leader in Pharmacy, she collaborates with medical management teams to develop programs that engage members and enhance “best-in-class” care management, while managing and improving Gateway’s pharmacy expenses across all business lines.

Previously, Ms. Pigg served as Senior Vice President of Pharmacy for Magellan Health, Inc., where she was responsible for strategic leadership, product innovation, performance improvement, sales and marketing support, customer satisfaction and quality. She has served as CEO of the Foundation for Managed Care Pharmacy and was a Vice President at Cigna Healthcare focusing on Trade Relations, Customer Service and Medical Cost Management.

Ms. Pigg holds an Masters in Health Administration from the Medical College of Virginia/Virginia Commonwealth University and B.S. degrees in Pharmacy and Medical Technology, as well as numerous awards and honors from national and state pharmacy associations. She is also a Fellow of the Academy of Managed Care Pharmacy.

Throughout his healthcare career, John’s mission has been to define and build unique programs that are recognized as “best in class” for patient experience and outcomes. With extensive experience from both the pharmaceutical manufacture and within a large integrated health system, John embraces the opportunity to connect specialty patients and their providers to manufactures, payers, plan sponsors, and others, to create a patient-centric, clinical care team model that produces superior, demonstrable results in patient care.

John is a proud graduate of the University of Georgia, receiving his Master’s in Business Administration and Marketing from the University of South Carolina.

Ray Tancredi is divisional vice president, Specialty Pharmacy Development Brand Rx/Vaccine Purchasing, at Walgreens, based in Deerfield, Illinois Tancredi oversees a team responsible for all specialty pharmacy trade functions including Specialty Pharmacy product access, including limited distribution and relationships, managing manufacturer hub services and referrals, contract negotiation, implementation and compliance, pharma programs and services, data analysis and reporting, RFP support and coordinating clinical, patient services, new drug in-services, and education. Additionally, he oversees management of strategic manufacturer accounts in an effort of maximize contracts and provide exceptional customer service. Tancredi also oversees the team responsible for brand prescription drug launches and vaccine procurement including flu vaccine, GPO relationships, and specialty pharmacy distributors.

EDUCATION: Tancredi earned his Bachelor of Science in Pharmacy from Temple University School of Pharmacy (1983) and is a registered pharmacist in PA and FL. He also holds a Master of Business Administration in Management from Eastern University (2001).

PROFESSIONAL MEMBERSHIPS: He is president of the Specialty Pharmacy Certification Board (SPCB) and is a Certified Specialty Pharmacist (CSP Certificate 032).

Joel Wright was named President and Chief Executive Officer of a combined specialty and mail services company with AllianceRx Walgreens Prime that launched on April of 2017. This combined company is a subsidiary of Walgreens, the Retail Pharmacy USA Division of Walgreens Boots Alliance, and will be headquartered in Chicago, Ill.

Mr. Wright previously was Divisional Vice President of Walgreens Specialty Solutions Group, a division dedicated to providing patients with complete specialized pharmaceutical care to treat chronic, rare or complex conditions. During his tenure from 2013 - 2016, Mr. Wright developed and executed a successful go-to-market strategy for five central specialty and 250 local specialty pharmacies throughout the U.S. and Puerto Rico. Under his leadership, the Specialty Solutions Group nearly doubled its sales and amassed more than $8 million in annual revenue.

Before leading the specialty division, Mr. Wright held a variety of leadership roles of increasing responsibility at Walgreens. He began his Walgreens career 22 years ago as a Pharmacy Manager and Supervisor and has since served as Vice President of Home Care, Executive Director of Pharmacy and Senior Director of Healthy System Operations.

Mr. Wright holds a Bachelor of Pharmacy degree from the Ferris State University in Grand Rapids, MI. He also completed the Executive Management Program for Pharmacy Leaders at University of Pennsylvania’s Wharton School of Business.